Skip to main content
. 1998 May 12;95(10):5562–5567. doi: 10.1073/pnas.95.10.5562

Figure 1.

Figure 1

Effects of βAP on PKCα and PKCγ immunoreactivity. Western blot analyses of monoclonal anti-PKCα or anti-PKCγ immunoreactivities in AC or AD fibroblasts before and after exposure to 10 nM βAP(1–40) for 48 h. (A) Visual inspection reveals decreased PKCα immunoreactivity after βAP(1–40) treatment in AC fibroblasts. (B) No modifications of PKCα immunoreactivity are visible in AD fibroblasts after treatment with βAP(1–40). (C) PKCγ immunoreactivity was decreased after treatment with βAP(1–40) in AD cells.